Lee, Danner & Bass’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.16M | Sell |
89,551
-1,463
| -2% | -$38.3K | 0.12% | 120 |
|
|
2026
Q1 | $2.56M | Sell |
91,014
-2,670
| -3% | -$71.1K | 0.16% | 105 |
|
|
2025
Q4 | $2.33M | Sell |
93,684
-10,934
| -10% | -$276K | 0.17% | 98 |
|
|
2025
Q3 | $2.67M | Sell |
104,618
-1,665
| -2% | -$41.1K | 0.19% | 91 |
|
|
2025
Q2 | $2.58M | Sell |
106,283
-8,986
| -8% | -$210K | 0.2% | 90 |
|
|
2025
Q1 | $2.92M | Buy |
115,269
+3,524
| +3% | +$92.2K | 0.24% | 84 |
|
|
2024
Q4 | $2.96M | Sell |
111,745
-14,496
| -11% | -$393K | 0.23% | 83 |
|
|
2024
Q3 | $3.65M | Sell |
126,241
-2,620
| -2% | -$76.4K | 0.26% | 78 |
|
|
2024
Q2 | $3.61M | Buy |
+128,861
| New | +$3.55M | 0.28% | 74 |
|
|
2023
Q4 | $3.93M | Sell |
136,645
-20,220
| -13% | -$611K | 0.34% | 70 |
|
|
2023
Q3 | $5.2M | Sell |
156,865
-489
| -0.3% | -$17.3K | 0.47% | 48 |
|
|
2023
Q2 | $5.77M | Sell |
157,354
-3,810
| -2% | -$148K | 0.5% | 43 |
|
|
2023
Q1 | $6.58M | Sell |
161,164
-15,348
| -9% | -$663K | 0.6% | 38 |
|
|
2022
Q4 | $9.04M | Sell |
176,512
-10,318
| -6% | -$495K | 0.85% | 30 |
|
|
2022
Q3 | $8.18M | Sell |
186,830
-2,340
| -1% | -$114K | 0.86% | 31 |
|
|
2022
Q2 | $9.92M | Sell |
189,170
-4,975
| -3% | -$254K | 1% | 25 |
|
|
2022
Q1 | $10.1M | Buy |
194,145
+1,774
| +0.9% | +$92K | 0.86% | 28 |
|
|
2021
Q4 | $11.4M | Sell |
192,371
-2,057
| -1% | -$102K | 0.97% | 26 |
|
|
2021
Q3 | $8.36M | Buy |
194,428
+1,182
| +0.6% | +$52.4K | 0.77% | 33 |
|
|
2021
Q2 | $7.57M | Buy |
193,246
+6,221
| +3% | +$242K | 0.69% | 41 |
|
|
2021
Q1 | $6.78M | Buy |
187,025
+1,651
| +0.9% | +$58.6K | 0.65% | 43 |
|
|
2020
Q4 | $6.82M | Buy |
185,374
+13,618
| +8% | +$500K | 0.73% | 38 |
|
|
2020
Q3 | $5.98M | Sell |
171,756
-3,033
| -2% | -$106K | 0.71% | 39 |
|
|
2020
Q2 | $5.42M | Sell |
174,789
-6,186
| -3% | -$210K | 0.69% | 43 |
|
|
2020
Q1 | $5.6M | Buy |
180,975
+10,879
| +6% | +$371K | 0.8% | 33 |
|
|
2019
Q4 | $6.32M | Buy |
170,096
+3,899
| +2% | +$139K | 0.66% | 42 |
|
|
2019
Q3 | $5.67M | Buy |
166,197
+2,471
| +2% | +$89.9K | 0.61% | 44 |
|
|
2019
Q2 | $6.73M | Sell |
163,726
-8,481
| -5% | -$337K | 0.71% | 40 |
|
|
2019
Q1 | $6.94M | Sell |
172,207
-2,554
| -1% | -$102K | 0.76% | 40 |
|
|
2018
Q4 | $7.24M | Sell |
174,761
-344
| -0.2% | -$14.3K | 0.85% | 33 |
|
|
2018
Q3 | $7.32M | Sell |
175,105
-4,551
| -3% | -$175K | 0.73% | 39 |
|
|
2018
Q2 | $6.18M | Buy |
179,656
+705
| +0.4% | +$24.1K | 0.66% | 42 |
|
|
2018
Q1 | $6.03M | Buy |
178,951
+4,425
| +3% | +$152K | 0.63% | 44 |
|
|
2017
Q4 | $6M | Sell |
174,526
-6,732
| -4% | -$230K | 0.61% | 44 |
|
|
2017
Q3 | $6.14M | Sell |
181,258
-1,431
| -0.8% | -$46K | 0.66% | 43 |
|
|
2017
Q2 | $5.82M | Buy |
182,689
+4,315
| +2% | +$136K | 0.65% | 42 |
|
|
2017
Q1 | $5.79M | Sell |
178,374
-2,936
| -2% | -$92.6K | 0.65% | 40 |
|
|
2016
Q4 | $5.59M | Sell |
181,310
-518
| -0.3% | -$15.8K | 0.66% | 41 |
|
|
2016
Q3 | $5.84M | Buy |
181,828
+3,076
| +2% | +$103K | 0.71% | 39 |
|
|
2016
Q2 | $5.97M | Sell |
178,752
-391
| -0.2% | -$12.5K | 0.72% | 38 |
|
|
2016
Q1 | $5.62M | Buy |
179,143
+58,246
| +48% | +$1.66M | 0.69% | 39 |
|
|
2015
Q4 | $3.7M | Buy |
120,897
+15,340
| +15% | +$483K | 0.48% | 53 |
|
|
2015
Q3 | $3.15M | Sell |
105,557
-1,467
| -1% | -$47K | 0.42% | 58 |
|
|
2015
Q2 | $3.4M | Sell |
107,024
-750
| -0.7% | -$24.4K | 0.41% | 57 |
|
|
2015
Q1 | $3.56M | Sell |
107,774
-988
| -0.9% | -$31.4K | 0.42% | 52 |
|
|
2014
Q4 | $3.21M | Sell |
108,762
-2,813
| -3% | -$80.7K | 0.38% | 54 |
|
|
2014
Q3 | $3.13M | Buy |
111,575
+1,479
| +1% | +$41.5K | 0.39% | 56 |
|
|
2014
Q2 | $3.1M | Buy |
110,096
+36
| +0% | +$1.03K | 0.38% | 58 |
|
|
2014
Q1 | $3.35M | Buy |
110,060
+3,670
| +3% | +$109K | 0.44% | 52 |
|
|
2013
Q4 | $3.09M | Sell |
106,390
-7,851
| -7% | -$228K | 0.41% | 54 |
|
|
2013
Q3 | $3.11M | Sell |
114,241
-853
| -0.7% | -$23.2K | 0.43% | 53 |
|
|
2013
Q2 | $3.06M | Buy |
+115,094
| New | +$3.18M | 0.45% | 53 |
|
Other funds holding PFE
AIM
SLAM
CWP
Lee, Danner & Bass's PFE Position: Q2 2026 in Review
Lee, Danner & Bass reduced its Pfizer (PFE) stake by 1.6% in Q2 2026, selling an estimated $38.3K and leaving 89,551 shares worth $2.16M. The position accounts for 0.12% of the portfolio, ranked #120.
Lee, Danner & Bass first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.4M in Q4 2021. 1,135 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Lee, Danner & Bass held 89,551 shares of Pfizer worth $2.16M as of Q2 2026.
- Lee, Danner & Bass sold 1,463 Pfizer shares in Q2 2026, an estimated $38.3K.
- Pfizer made up 0.12% of Lee, Danner & Bass's portfolio in Q2 2026, its #120 holding.
- Lee, Danner & Bass first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Lee, Danner & Bass's Pfizer position peaked at $11.4M in Q4 2021.
- 1,135 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.